Clinical Trials Browser

Has results × Neoplasms × regorafenib × Clear all

NCT02168777 2018-01-26

Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer

Phase 1 Terminated

20 enrolled 28 charts

Neoplasms

NCT01853046 2017-02-20

Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment

Phase 1 Completed

24 enrolled 30 charts

Neoplasms, Renal Insufficiency

NCT01117623 2015-11-18

Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies

Phase 1 Completed

86 enrolled 33 charts

Neoplasms